Markets

News Details

( 02 May 2018)
Cipla - Press Release

Cipla Limited has informed the Exchange regarding a press release dated May 02, 2018, titled "Cipla Receives Final Approval for Generic Vazculepr,Generic Phenylephrine Hydrochloride Injection USP, 10mg/mL Single-Dose Vial and Generic Aromasinr".